Last reviewed · How we verify

NCT06223776

Effects of Sleep Restrictions on Maximal Strength, Muscle Power, and Strength Endurance in Resistance-trained Women.

ENROLLING BY INVITATION NA Last updated 11 April 2024
What this trial tests

NA trial testing Sleep restriction in Sleep Restriction in 20 participants. Enrolling by invitation.

Timeline
15 May 2023
Primary endpoint
1 August 2024
1 August 2024

Quick facts

Lead sponsorUniversity School of Physical Education, Krakow, Poland
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposediagnostic
Enrollment20
Start date15 May 2023
Primary completion1 August 2024
Estimated completion1 August 2024
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University School of Physical Education, Krakow, Poland

Who can join

Adults 18 to 30, female only, with Sleep Restriction or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to see how acute sleep restriction will affect women resistance trainers. Above all, the investigators will be interested in observing the relationship between shorter sleep and athletic performance, as well as other important aspects, such as their level of motivation to exercise, how much pain participants felt during exercise and how demanding they found exercise. The investigators assume that differences in subjective measures (such as pain levels, motivation and mood) will be most apparent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sleep restriction

Trials testing the same drug.

Other recruiting trials for Sleep Restriction

Currently open trials in the same condition.

Other University School of Physical Education, Krakow, Poland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06223776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing